跳至主要内容
临床试验/CTRI/2019/01/017091
CTRI/2019/01/017091招募中3 期

Open label, randomized, controlled trial to compare the efficacy of daily therapy with low dose prednisolone versus standard therapy on alternate days in patients with frequently relapsing/steroid dependent nephrotic syndrome

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children aged 2-18 yr with frequently relapsing or steroid dependent nephrotic syndrome
  • Written informed consent from parents

排除标准

  • Steroid resistant nephrotic syndrome
  • Congenital nephrotic syndrome
  • Nephrotic syndrome secondary to systemic disease (systemic lupus erythematosus, IgA nephropathy, infection with HIV or hepatitis B or C)
  • Estimated glomerular filtration rate below 60 ml/min/1.73 sq. m
  • Recent (during the last 6-months) therapy with long term alternate day prednisolone for >3-months, levamisole, cyclophosphamide or mycophenolate mofetil
  • History of therapy with cyclosporine, tacrolimus or rituximab
  • Significant steroid toxicity, as defined by BMI >2 SDS; stage 2 hypertension; cataract, glaucoma; fasting glucose levels >100 mg/dl; history of steroid psychosis

研究者

相似试验

招募中
4 期
A study to compare efficacy of daily prednisolone versus standard alternate day prednisolone in patients with frequently relapsing nephrotic syndrome.
CTRI/2012/12/003194Council of Scientific and Industrial Research60
进行中(未招募)
1 期
Clinical study aimed to compare tocilizumab to anti-TNF treatment and to discover biomarkers for treatment selection in rheumatoid arthritis patients with inadequate response to a first anti-TNFRHEUMATOID ARTHRITISMedDRA version: 20.0Level: LLTClassification code 10037738Term: R arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10039014Term: Rh arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-001987-12-ITSOCIETA' ITALIANA DI REUMATOLOGIA - SIR208
已完成
不适用
An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
JPRN-UMIN000001033Okayama University Hospital240
进行中(未招募)
不适用
Randomised, controlled open label trial to compare the efficacy safety and tolerability of a treatment simplification by darunavir/ritonavir DRV/r 800/100 mg OD vs a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments - TMC114HIV3006HIV-1 patients with plasma RNA HIV-1 undetectable in current treatmentMedDRA version: 9.1Level: LLTClassification code 10049829Term: Blood HIV RNA below assay limit
EUCTR2006-006437-40-ITJANSSEN-CILAG INTERNATIONAL N.V.250
尚未招募
不适用
EVETERACETAM VS SODIUM VALPROATE
CTRI/2020/09/027792government medical college and hospital aurangabad